
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, according to a new Northwestern study.

Every 40 seconds, someone in the U.S. has a stroke, according to the Centers for Disease Control and Prevention. Investigators at Feinberg are working from multiple angles of the stroke care pathway, leading to research that may improve recovery after a stroke occurs.

A new study from the laboratory of Gemma Carvill, PhD, has uncovered variants in noncoding regulatory regions of the genome that contribute to the development of neurodevelopmental disorders, findings that could help spearhead the development of more effective precision therapeutic strategies.

Northwestern University is accepting nominations for its $250,000 Kimberly Prize in Biochemistry and Molecular Genetics. The annual prize will be awarded in 2027. The Prize is the largest biochemistry award offered in the U.S.

A landmark international study has found that the genetic drivers of Parkinson’s disease can vary dramatically between populations, underscoring the need to include people of various ancestries in genetic research and clinical trials.

Northwestern Medicine scientists have uncovered how a major Parkinson’s disease gene disrupts the brain’s most vulnerable dopamine-producing neurons before detectable neuronal loss, according to findings published in Nature Communications.

Northwestern Medicine investigators have received an R01 research grant from the National Heart, Lung, and Blood Institute to evaluate a new simulation-based mastery learning curriculum to help patients and their caregivers improve self-care for chronic heart disease.

Northwestern scientists have developed a DNA-driven process to induce protein crystallization that can help reveal protein structures and enable the development of new flexible biomaterials.

New Northwestern Medicine research published in Nature Communications suggests that a metabolite produced by gut bacteria when they digest dietary fiber can leave a lasting molecular imprint on intestinal cells, promoting immune tolerance and protecting against inflammatory bowel disease-like conditions long after exposure ends.

A recent Northwestern Medicine study offers new data showing previously unknown genetic variants that cause the development of tuberous sclerosis complex, a rare genetic disorder that causes benign tumors to develop in many parts of the body, according to findings published in Nature Communications.